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Birthweight reflects in utero exposures and later health evolution. Despite existing studies employing
high-dimensional molecular measurements, the understanding of underlying mechanisms of birthweight
remains limited.
Methods
To investigate the systems biology of birthweight, we cross-sectionally integrated the methylome, the
transcriptome, the metabolome and a set of inflammatory proteins measured in cord blood samples,
collected from four birth-cohorts (n = 489). We focused on two sets of 68 metabolites and 903 CpGs
previously related to birthweight and investigated the correlation structures existing between these two sets
and all other omic features via bipartite Pearson correlations.
Results
This dataset revealed that the set of metabolome and methylome signatures of birthweight have seven
signals in common, including three metabolites [PC(34:2), plasmalogen PC(36:4)/PC(O-36:5), and a
compound with m/z of 781.0545], two CpGs (on the DHCR24 and SC4MOL gene), and two proteins
(periostin and CCL22). CCL22, a macrophage-derived chemokine has not been previously identified in
relation to birthweight. Since the results of the omics integration indicated the central role of cholesterol
metabolism, we explored the association of cholesterol levels in cord blood with birthweight in the
ENVIRONAGE cohort (n = 1097), finding that higher birthweight was associated with increased
high-density lipoprotein cholesterol and that high-density lipoprotein cholesterol was lower in small versus
large for gestational age newborns.
Conclusions
Our data suggests that an integration of different omic-layers in addition to single omics studies is a useful
approach to generate new hypotheses regarding biological mechanisms. CCL22 and cholesterol
metabolism in cord blood play a mechanistic role in birthweight.
Abbreviations: AGA, adequate for gestational age; BMI, body mass index; DOHaD, Developmental
Origin of Health and Disease; HDL, high-density lipoprotein; IL, interleukin; IQR, interquartile; LGA,
large for gestational age; LDL, low-density lipoprotein; m/z, mass-to-charge ratio; ORA,
overrepresentation analysis; SGA, small for gestational age; PC, phosphatidylcholine; U, unassigned
metabolite; 95CI, 95% confidence interval
Keywords: Birth weight, Cholesterol, DNA methylation, Gene expression, Metabolome, Proteins
1. Introduction
The Developmental Origin of Health and Disease hypothesis (DOHaD) states that later life diseases may
be influenced by experiences and conditions in prenatal life [1]. It is hypothesized that the interplay
between genotype and in utero environmental factors induces molecular modifications and possibly
phenotype differentiation in the fetus [2]. This developmental plasticity is of crucial importance for
postnatal life but can induce impairments related to adverse health outcomes [3]. For example, exposure to
detrimental environmental factors may induce birthweight changes that in turn may be associated with
increased mortality or risk of cardiovascular diseases, mental health problems, and some cancers later in
life [[4], [5], [6], [7]]. Among several mechanisms proposed to explain the link between in utero exposures,
birthweight and health and diseases in later life, molecular markers identified through “omics” platforms,
may play a central role. The theoretical foundation that drives the present study is that birthweight induces
molecular modifications that in turn influence later life health, as exemplified in the Fig. 1, however is also
possible that birthweight is influenced by molecular changes determined by in utero exposures.
Recently two studies based on high-dimensional molecular measurements in cord blood identified DNA
methylation signals and metabolites associated with birthweight: 914 differentially methylated CpG sites
were discovered in 8825 neonates from 24 birth-cohorts and 68 metabolites were identified in 499
neonates from four birth-cohorts [8,9]. These studies, together with several metabolomic, gene expression,
proteomic, genomic, and epigenomic analyses, have increased our understanding of underlying
mechanisms of birthweight [[10], [11], [12], [13], [14], [15], [16], [17], [18], [19], [20]]. However, a study
integrating multi-omic levels in cord blood associated with birthweight in the same samples has not yet
been performed.
To decipher at several levels the molecular cascades that regulate birthweight, in this paper we propose to
integrate DNA-methylation, gene expression data as well as metabolic profiles and a set of inflammatory
proteins measured in cord blood samples (n = 489) collected from four independent population-based birth-
cohorts [21]. We used two birthweight-related sets of molecular signals, metabolites [8] and DNA
methylation levels [9], to drive the integrated analyses and translated these signals to the other omic layers
in the same samples. Based on results common to the metabolite- and methylation-driven multi-omic
integrations, we aimed to identify key molecular associations with birthweight.
2. Material and methods
2.1. Study population and samples collection
Our study population arises from the EXPOsOMICS European project and includes 500 newborns from
four population-based cohorts: 200 newborns from ENVIRONAGE, 100 from INMA, 99 from Piccolipiù,
and 101 from Rhea [[21], [22], [23], [24], [25]]. Inclusion criteria and protocols are detailed in the
respective cohort descriptions and in the Supplementary methods. Before the placenta was delivered,
whole blood was withdrawn from cord vessels and immediately frozen at −80 °C. Samples were sent to
different laboratories for metabolome, inflammatory proteins and DNA methylome analysis [21]. The
transcriptome was measured for the 200 ENVIRONAGE samples participating in the EXPOsOMICS
project and cholesterol was measured for the entire ENVIRONAGE cohort.
2.2. Metabolomic profiles
Untargeted metabolomics was performed as previously described [8] and detailed in the Supplementary
Methods. Briefly, reversed phase liquid chromatography-quadrupole time-of-flight mass spectrometry
(UHPLC-QTOF-MS) system was used in positive ion mode with 499 of the 500 samples successfully
analyzed. Raw data preprocessing was performed with Agilent MassHunter software, and metabolic
features present in <60% of the samples were excluded, leaving 4712 features for 499 samples available
for the subsequent analysis. Data were log-transformed and missing values were imputed using the impute.
QRILC function within the “imputeLCMD” R package. Identification of the features of interest was done
as previously described by Robinson et al. [8] and level of identification was reported as proposed by
Sumner et al. [26].
2.3. DNA methylation profiles
Genomic DNA was extracted from buffy coats according to standard protocol and underwent bisulphite
conversion using the Zymo EZ DNA methylationTM kit (Zymo, Irvine, CA, USA), hybridization to
Illumina HumanMethylation 450K BeadChip arrays and scanning using an Illumina iScan. As detailed in
the Supplementary Methods and elsewhere, we used in-house software to preprocess the data, including
removal of probes based on signal intensities and control probes, background subtraction and dye bias
correction [27]. After quality control and filtering, 417572 CpG sites for 460 samples were retained for
subsequent analysis and methylation levels were expressed as beta values. To account for technically-
induced and tissue-related variation in the methylation levels, we ran a preliminary linear model for the
methylation beta values (as outcome variable) adjusting for technical variation (array row and position on
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the chip), as well as estimated cell type composition using the Bakulski method [28].
2.4. Gene expression
Gene expression levels were measured in cord blood samples (n = 200) of the ENVIRONAGE cohort.
RNA was extracted using the total RNA miRNeasy mini kit (Qiagen, Venlo, Netherlands) according to the
manufacturer's protocol. As detailed in the Supplementary Methods, samples were quality checked and
further hybridized onto Agilent Whole Human Genome 8 × 60 K microarrays coupled with Agilent DNA
G2505C Microarray Scanner. After preprocessing, quality control, and normalization detailed in the
Supplementary methods, 29164 transcripts for 165 samples were left available for further analysis. To
account for technical noise, we ran a linear model for the observed gene expression level (as outcome
variable) adjusting for technical variation (hybridization date) and white blood cells count.
2.5. Inflammatory proteins
We measured 22 inflammation-related proteins using an R & D Luminex screening assay according to the
protocol described by the manufacturer, and c-reactive protein using Solid Phase Sandwich ELISA.
Excluding proteins detected in <40% of the study population, we were left with 16 inflammatory proteins
(Supplementary Table 1) measured in 493 samples, of which three were excluded. For the remaining 490
samples missing values were imputed following an approach based on likelihood maximization estimation
procedure [29]. Protein concentrations were subsequently log-transformed, and to correct for nuisance
variation, we employed the same linear model approach described before setting the plate identification as
technical covariate.
2.6. Cholesterol
The plasma levels of high-density lipoprotein (HDL), low-density lipoprotein (LDL), and total cholesterol
were measured in entire ENVIRONAGE population using Cobas 8000 C702 module analyzer (Roche,
Basel, Switzerland). Outliers (>5 standard deviations from mean) were excluded from the analyses.
Respectively 1139, 1109 and 1131 samples had valid HDL, LDL, and total cholesterol measurements.
2.7. Anthropometrics and covariates
Birthweight in grams was collected from medical records. In ENVIRONAGE cohort, newborns were
classified as small for gestational age (SGA), adequate for gestational age (AGA) or large for gestational
age (LGA) if their birthweight for given gestational age, sex, and parity status was respectively below the
10th percentile, between 10th percentile and 90th percentile, or above the 90th percentile calculated for
Flanders from the Study Centre for Perinatal Epidemiology (http://www.neonatologie.ugent.be
/SPE-standaarden.pdf).
As detailed in the Supplementary Material, covariates were selected based on previous reported
associations with birthweight and included: sex of the newborns, parity, gestational age, maternal and
paternal age and body mass index (BMI), maternal smoking status during pregnancy, and maternal
education.
2.8. Statistical analyses
The study design is schematically represented in Fig. 2.
We adopted an exposome globe approach to
investigate the correlation structures across the omic measurements available in our study population and
investigated Pearson's correlation coefficients for pairs of omics measurement [30]. We used sets of
molecular features from two omic platforms to drive our integrated analyses [31]: (a) a set of 68
metabolites previously associated with birthweight (Supplementary Table 2); and (b) a set of 903 (available
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from the total of 914, Supplementary Table 2) CpGs previously associated with birthweight [8,9]. These
sets were correlated with all the other untargeted omic features. The statistical significance of all
correlation coefficients was assessed by deriving a z-score from Fisher transformation and running a
Student's t-test test assessing the null hypothesis of no correlation H  : ρ = 0. We corrected for multiple
testing using the stringent Bonferroni correction for the number of tests (i.e. the total number of pairs
investigated) and considered significant the correlations with Bonferroni corrected p-values<0·05. The
number of samples participating in each analysis is presented in Supplementary Table 3. Results were
visualized by means of Circos plots (Circos software version 0.69–6), where only significant correlation
coefficients were reported.
In order to assess if our results were biased by heterogeneity between the different cohorts, we used linear
models adjusted on the factors differing across cohorts (namely: gestational age, parental ages, weights and
heights, parity and maternal education) to test associations between features significantly correlated in our
main analyses. Stratification by sex was performed as a sensitivity analysis in order to take into account the
birthweight sexual dysmorphism [32].
Finally, we compared the metabolite- and the methylation-driven results to assess if any metabolite-CpG
pairs and any omic were in common.
We performed overrepresentation analyses (ORA) of all transcripts and CpGs
significantly correlated in the metabolite-driven analyses and of the CpG significantly correlated with
metabolites in the metabolite-driven analysis using ConsensuspathDB online tool
(http://consensuspathdb.org/). A pathway was considered significantly enriched if p-values were smaller
than 0·05 and included at least 3 genes.
Enriched metabolic pathways within metabolic features correlated with CpGs in the methylation-driven
analyses were identified using the mummichog program (version 1.1.0) [33] through the MetaboAnalyst
platform [34]. We used all mass-to-charge ratio (m/z) values and associated p-values of the metabolic
features as software input and set mummichog parameters to ‘positive mode’ at ±5 ppm mass tolerance.
The p-value cutoff to identify the list of significant m/z features was set to false discovery rate adjusted
(FDR) p-value equal to 0·05, with the non-FDR significant features used as the reference set. The
algorithm searches tentative compound lists from metabolite reference databases against an integrated
model of human metabolism to identify functional activity. A pathway was considered significant if gamma
adjusted p-values were smaller than 0·05. Visualization of enriched pathways on the KEGGscape network
was performed through the MetaboAnalyst platform [34].
We selected all significantly correlated omic features in the main
analyses and performed network correlation analysis. Correlation networks were plotted using “igraph”
package with layout algorithm by Fruchterman and Reingold (version 0.7.1). Only nodes with degree >2
and edges with Bonferroni corrected p-values <0·05 were represented in the networks. Communities were
detected using the Louvain algorithm.
We searched SNPs associated with the
CpG sites significantly correlated to the other omic layers in the publicly available methylation quantitative
trait loci (mQTL) database (http://www.mqtldb.org/). We compared the localization on the genome of 233
SNPs associated with own birthweight and 128 SNPs associated with offspring birthweight in the
NHGRI-EBI GWAS Catalog with the identified methylation signals (±2 Mb from the genetic variants) and
we searched for mQTL associated with these SNPs [35].
Based on omics identified in significant pairs
from both the metabolite- and methylation-driven analyses, we generated a hypothesis on mechanisms
underlying birthweight. Common omic signals that were significantly correlated with both the metabolite
and CpGs birthweight-related sets, were associated with cholesterol metabolism. We ran linear regression
models to assess (i) the associations between omics identified in our multi-omic analyses and cholesterol
0
levels and (ii) the association between birthweight and cholesterol levels. These analyses were restricted to
the ENVIRONAGE cohort. All the models were adjusted for gestational age, parity, newborn sex, maternal
age, maternal height, maternal BMI, smoking during pregnancy and maternal education, total cholesterol
levels (for HDL and LDL analyses), plate (for proteins analyses), cell types composition, array row and
position on the chip (for CpGs analyses). Paternal age and anthropometric measurements were not
included as adjustment covariates due to missingness. In addition, we used linear models adjusted for the
covariates aforementioned to explore if being SGA, AGA and LGA (independent variable) was associated
with the levels of omic markers identified and cholesterol (dependent variable). If p-values were smaller




Descriptive characteristics of the study population participating in the main multi-omic study are presented
by cohort in Table 1 and by sex in Supplementary Table 4 and indicate heterogeneity across cohorts for all
covariates, except proportion of girls born and maternal smoking habits during pregnancy.
3.2. Metabolite-driven integration of omics
By correlating the set of (n = 68) metabolites (Supplementary Table 2), previously reported in these same
four birth-cohorts to be associated with birthweight by Robinson and colleagues, with the other omic layers
we identified 347 significantly correlated omic pairs involving 208 omic features (47 metabolites, 15
inflammatory proteins, 71 transcripts and 75 CpGs) (Fig. 3A and Supplementary Table 5) [8].
Pairs involving transcripts were all positively correlated to metabolites (Supplementary Figs. 1A and 2B),
68% of the metabolite-inflammatory protein pairs were positively correlated (Supplementary Figs. 1C and
2C) while 82% of the significant metabolite-CpG pairs showed negative correlation coefficients
(Supplementary Figs. 1B and 2A). The strongest correlation coefficients in absolute value were observed in
pairs involving transcripts (absolute range r = 0·42–0·54), followed by pairs involving CpG sites (absolute
range r = 0·28–0·39), and inflammatory proteins (absolute range r = 0·18–0·44) (Table 2).
We did not identify one single metabolite related to all three of the other omic layers (Fig. 3B and
Supplementary Table 6). Progesterone was the annotated metabolite correlated with most omic features
(n = 47), including both proteins and transcripts.
The identified transcriptome signals were involved in 31 significant pathways (p-values<0·05), mainly
related to immune response [e.g. Interleukin (IL)12-mediated signaling events and natural killer cell
mediated cytotoxicity] (Fig. 3C and Supplementary Table 7). Similarly, the identified CpGs signals were
mapped into seven significant pathways (p-values<0·05) including TNFalfa, thermogenesis, and insulin
signaling pathways (Fig. 3C and Supplementary Table 7).
To further characterize the 208 omic signals identified in the metabolite-driven analysis, we constructed a
correlation network. This network analyses revealed that identified molecules were mainly grouped in
distinct communities according to their omic layer (Fig. 3D). In all groups, except group 4, signals of other
omics were also present, e.g. progesterone and other four unassigned metabolites (U4, U5, U6 and U46)
that were grouped with the transcripts (group 2) (Supplementary Table 8). The network analysis unveiled
novel correlations between proteins and CpGs groups but not between transcripts and CpGs or transcripts
and proteins.
No mQTL was identified for the identified 75 CpG sites. One to six significant CpG sites were located
±2 Mb from 153 SNPs out of the 233 associated with own birthweight and from 39 SNPs out of the 128
SNPs associated with offspring birthweight (Supplementary Table 9). One SNP, associated with own
birthweight, was located in the same gene (PDE4B) as a significant CpG.
Sensitivity analyses agreed mostly with the main analyses, except for transcripts. 29 metabolites were still
significantly associated with 32 omic features (17 CpG sites and 15 proteins) after adjustment for
gestational age, parental ages, parental weights and heights, parity and maternal education (Supplementary
Table 10). Out of the total 347 significant correlations from the main analyses, after stratification by sex,
62 correlations remained significant in boys and 46 in girls (Supplementary Fig. 3), three additional
correlations became significant in boys and five in girls (Supplementary Table 11).
3.3. Methylation-driven integration of omics
By correlating a set of 903 CpG sites that have been previously associated with birthweight by Kupers and
colleagues (Supplementary Table 2) with the other omic layers, we identified 482 significant pairs involving
241 omic measurements (58 CpGs, 157 transcripts, two proteins, 24 metabolic features) (Fig. 4A,
Supplementary Table 12) [9].
As indicated in Table 3, most of the CpG-transcript and CpG-inflammatory protein pairs were negatively
correlated (92% and 75% respectively, see Supplementary Figs. 4A,C and 5A–B), and the pairs involving
metabolites were predominantly positively correlated (79%, Supplementary Figs. 4B and 5C).
The strongest correlations were observed in the CpG-transcript pairs (absolute range r = 0·45–0·57),
followed by CpG-metabolic feature pairs (absolute range r = 0·26–0·39) and CpG-inflammatory protein
pairs (absolute range r = 0·22–0·24).
No CpG site was correlated to all three types of omic data (Fig. 4D and Supplementary Table 13).
cg08217545 (located on the NFIC gene) was the CpGs involved in the most significant correlations
(n = 86). Pathways analysis of the identified transcriptome signals resulted in 17 enriched pathways (Fig. 4
B and Supplementary Table 14), mostly involved in signal transduction and immune system (such as G
beta:gamma signaling through PI3Kgamma and TNF signaling pathway).
The 24 metabolic features identified were found to represent 14 unique compounds, of which nine could
be identified [Unidentifiable phosphatidylcholine (PC)/LysoPC, PC(30:0), PC(34:2), PC(36:4),
Plasmalogen PC(38:4) or PC(O-38:5), Plasmalogen PC(36:4) or PC(O-36:5), Plasmalogen PC(36:3) or
PC(O-36:4), Cholesterol, Cholestenone]. Full details on retention times masses, and levels of identification
are reported in Supplementary Table 15, with the chromatograms and mass spectra in the Additional data.
Pathways analysis for the metabolic signals identified (n = 201 metabolic features with 0·05 FDR adjusted
p-values) revealed three significantly enriched pathways including C21-steroid hormone biosynthesis and
metabolism, porphyrin metabolism and omega-3 fatty acid metabolism (Fig. 4C).
Network correlation analysis identified omics grouped in three multi-omic communities of transcripts and
CpGs (groups 1, 2 and 5) and three communities mainly or uniquely populated by a single omic type, e.g.
groups 3 and 4 are only made of transcripts (Fig. 4E and Supplementary Table 16). The network analysis
unveiled novel correlations between metabolites and proteins, and metabolites and transcripts.
Three mQTLs were identified for the 58 significant CpG sites (Supplementary Table 17). None of these
three mQTLs has been previously associated with birthweight. We identified one to seven significant CpG
sites located ±2 Mb from 188 SNPs out of the 233 associated with own birthweight and from 96 SNPs out
of the 128 associated with offspring birthweight (Supplementary Table 18). Only one SNP associated with
own birthweight was located in the same gene (PIM3) as a significant CpG site.
In sensitivity analyses 13 CpGs were still significantly associated with 24 omics (seven metabolic features
and 17 transcripts) after adjustment for gestational age, parental ages, weights and heights, parity and
maternal education (Supplementary Table 19). After stratification by sex, of the 482 correlations
significant in the main analyses four remained significant in boys and nine in girls (Supplementary Fig. 6),
four additional correlations became significant in boys and four in girls (Supplementary Table 20).
3.4. Signals in common between the metabolite- and methylation-driven integration of
omics
We identified seven features in common to both the metabolite- and the methylation-driven integration of
omics (Fig. 5A and Supplementary Table 21) which are part of 48 unique correlation pairs.
The seven features include three metabolites [PC(34:2), plasmalogen PC(36:4)/PC(O-36:5), and an
unidentifiable compound (U)61 of m/z 781.0545], two CpG sites (cg17901584 on the DHCR24 gene, and
cg05119988 on the SC4MOL gene), and two proteins (CCL22 and periostin).
No feature was in common between all omic-layers (Fig. 5B).
Despite that no single transcript was in common, pathways related to immune system and signal
transduction were enriched in both metabolite- and the methylation-driven integration of omics (Fig. 5D)
and the “chemokine signaling pathway” in particular was significant in both analyses, along with pathways
involving IL-2 and JAK-STAT signaling (Supplementary Tables 7 and 14).
Network correlation analysis confirmed the three metabolites were correlated with the two CpGs (Fig. 5C).
No feature was found to be robust to adjustment for factors differing by cohorts (Supplementary Table 22).
As both genes in which the common CpG sites are located are involved in cholesterol biosynthesis we
hypothesized that cholesterol metabolism is associated with birthweight and the newly identified omics
signals and consequently followed-up our analyses with a verification study in the ENVIRONAGE cohort.
3.5. Cholesterol analysis
To test our hypothesis that cholesterol is related to birthweight and birthweight related molecules, we
analyzed the measured levels of each of the seven omics features, common to both the metabolite- and the
methylation-driven omic integration, in relation to cord blood measurements of cholesterol available in the
ENVIRONAGE cohort (Supplementary Tables 3 and 23). Regressions models were adjusted for gestational
age, parity, newborn sex, maternal age, maternal height, maternal BMI, smoking during pregnancy,
maternal education, total cholesterol levels (for HDL and LDL analyses), plate (for proteins analyses), cell
types composition, array row and position on the chip (for CpGs analyses). We found that an interquartile
(IQR) increment of all three metabolic features [PC(34:2), plasmalogen PC(36:4)/PC(O-36:5) and U61],
and the two CpG sites, cg05119988 (on the SC4MOL gene) and cg17901584 (on the DHCR24 gene), were
respectively associated with an increase in total cholesterol levels of 17, 27, 18, 6, 7 mg/dl (p-value<0·01
for all the associations) (Table 4). Additionally, a IQR-increment of plasmalogen PC(36:4)/PC(O-36:5) was
associated with an increase of 5 mg/dl of HDL cholesterol (p-value = 0·01) (Table 4).
Analyses stratified by sex showed similar results for total cholesterol in girls and boys (only the p-value of
association with CpGs lost statistical significance in girls). Associations involving HDL cholesterol lost
statistical significance in the girls' analyses (Supplementary Table 24).
In a larger subset of the ENVIRONAGE cohort (n = 1096) (Supplementary Tables 3 and 23), we found that
an IQR-increment in birthweight (equal to 618 g) was associated with an increment 1·14 mg/dl of HDL
cholesterol [95% confidence interval (95CI) = 0·43 mg/dl to 1·85 mg/dl, p-value = 1·71e-03] upon adjusted
for gestational age, parity, newborn sex, maternal age, maternal height, maternal BMI, smoking during
pregnancy and maternal education (Supplementary Table 25). Analyses stratified by sex confirmed this
association in girls only (Supplementary Table 25).
Finally, we tested if the levels of omic markers identified and cholesterol differ in SGA, LGA and AGA
newborns. Among the seven omic markers identified only methylation of the two CpG sites, cg05119988
(on the SC4MOL gene) and cg17901584 (on the DHCR24 gene), was significantly higher in SGA
compared to LGA (p-value = 0·03 and 0·01, respectively), and methylation of cg17901584 was
significantly lower in LGA compared to AGA (p-value = 0·03) (Supplementary Table 26). Total cholesterol
was significantly lower (estimate change = −4·68 mg/dl, 95CI = −8·84 mg/dl to –0·50 mg/dl) in SGA
compared to AGA newborns (p-value = 0·03) and HDL cholesterol was significantly lower (estimate
change = −2·17 mg/dl, 95CI = −4·24 mg/dl to −0·09 mg/dl) in SGA compared to LGA newborns
(p-value = 0·04) (Fig. 6). In the analyses stratified by sex, HDL cholesterol levels were lower in SGA girls
compared to both AGA (p-value = 0·05) and LGA (p-value = 0·03) (Supplementary Table 25).
4. Discussion
Through an in-depth exploration of birthweight-associated sets of metabolites and methylation sites we
have identified commonalities and differences between signals from two different molecular layers [8,9].
From millions of correlations between omic molecules measured in cord blood, our study shows that the set
of metabolome and methylome signatures of birthweight have seven signals in common, one of which, the
macrophage-derived chemokine CCL22, has not been previously identified in relation to birthweight.
CCL22 was negatively correlated to both the metabolite PC(C34:2) and cg17901584 on the DHCR24
gene. CCL22 plays a crucial role in the control of T cell immunity [36]. Similarly, we found that the
“Chemokine signaling pathway” identified through the gene expression analysis, overlaps between the
metabolite- and methylation-driven analyses, supporting a potential link between birthweight and the
immune system.
Although a detailed discussion of specific molecules is beyond the purpose of the present study and
requires further experimental validation, we highlight here the example of progesterone, which was the
annotated metabolite most frequently correlated in metabolite-driven analyses. Higher levels of
progesterone in cord blood are observed with lower-weight births [8,37]. Progesterone plays an important
role in the suppression of immune responses promoting cord blood T cell differentiation [38]. Furthermore,
we observed that progesterone was clustered with transcripts that were most enriched for the IL-12
signaling pathway, which promotes Th1 differentiation and forms a link between innate resistance and
adaptive immunity [39]. In the methylation-driven analyses, JAK3 was the most frequently correlated
transcript and the JAK-STAT signaling pathway, which plays a critical role orchestrating innate and
adaptive immunity, was also significant enriched in the gene expression pathway analysis [40]. No previous
study has linked this enzyme to birthweight, yet experimental evidence has associated JAK3 with low
grade inflammation, obesity and metabolic syndrome [41]. Progesterone and JAK3 are two signals of many
we identified, that illustrate how the cross-omic approach can provide deeper insight in the biological
underlying mechanisms of birthweight and highlight avenues for further investigation.
In general, by comparing the metabolite- and methylation-driven analyses we could observe that: i)
phosphatidylcholine metabolites, particularly plasmalogens, have been identified in both analyses.
Maternal plasmalogens, that are able to cross the placenta, have been recently associated with newborn
body composition [42]. However, most previous studies identified lysoPCs rather than PCs as dominant
cord blood metabolites related to birthweight [15,18]. ii) In both analyses, metabolites were grouped with
two CpGs, albeit different CpGs (cg05119988 and cg17901584 in the metabolite-driven analysis and
cg14195992 and cg15331996 in the methylation-driven analysis). iii) The metabolite-driven network
analysis showed relations to groups of features from distinct omic layers while in the methylation-driven
analysis three groups contain a mix of different omic types, representing a more profound multi-omics
signal. iv) In both analyses we consistently found stronger correlations with gene expression-methylation
and gene expression-metabolites than between the other layers. v) Both analyses identified different gene
expression signals which suggests that post-transcriptional regulation is specific for metabolites or
methylation signals. vi) Metabolite-CpG pairs in the metabolite-driven analyses were mainly negatively
correlated, while in the methylation-driven analyses the opposite was observed. The latter difference may
arise from the fact that expression levels of genes are positively correlated with the level of methylation
within the transcribed region and while only 12% of the CpGs related to metabolites in the metabolite-
driven analysis were located in the gene body - this percentage increased to 46% in the methylation-driven
analysis. In the methylation-driven analyses the various negative associations may be due to the large
proportion of negative correlations between transcripts and methylation sites (92%), conversely, a single
cell study previously described a more complex relation depending on the location of CpG islands [43]. In
addition, the analyses showed a general trend for metabolite candidates being positively correlated with
gene expression, in agreement with previous literature [44].
CpGs in common between the methylation- and metabolite-driven integrations of omics belong to genes
(DHCR24 and SC4MOL) involved in cholesterol biosynthesis. Furthermore, C21-steroid hormone
biosynthesis and metabolism was identified as an important metabolic pathway both through our
methylation-driven analysis and in direct association with birthweight by Robinson et al. [8]. We therefore
performed a verification study in the ENVIRONAGE cohort and showed that plasmalogen
PC(36:4)/PC(O-36:5) was positively associated with HDL cholesterol levels that in turn were positively
associated with higher birthweight. Phosphatidylcholine metabolism, and in particular plasmalogens, may
regulate several important cholesterol biosynthesis processes which improve cholesterol sensing and
facilitate interorganelle cholesterol trafficking [45]. During fetal development cholesterol and
phospholipids are needed to build membranes, to develop the central nervous system including the brain
and they are precursors of bile acids and steroid hormones [46]. While in adults LDLs are the major
plasma lipoproteins, at birth cord blood is richer in HDLs because HDLs are produced in blood circulation
and are not dependent upon fetal liver production, conversely to LDLs [47]. In our study the positive
association between birthweight and HDL cholesterol was further confirmed by the finding of SGA having
decreased HDL cholesterol levels compared to LGA newborns. Further, we also found decreased total
cholesterol levels in SGA compared to both AGA and LGA newborns. Inconsistent (mostly null)
associations of cord total and HDL cholesterol levels with birthweight and between SGA and AGA, that
have been previously reported in literature [[48], [49], [50], [51], [52], [53], [54], [55]], may be due to
limited sample size or lack of adequate control regarding confounding. Conversely, positive associations
between birthweight and HDL cholesterol, in line with our results, have been described by a randomized
control trial in 343 obese pregnant women and an observational study in 1522 newborns upon adjustment
for main confounders [16,56]. Further, this last study found lower total and HDL cholesterol levels in 105
SGA compared to 1320 AGA newborns. Beyond the traditional association of increased cardiovascular
risk with concentrations of total and HDL cholesterol, HDL may have beneficial or detrimental effects on
systemic inflammation, obesity and diabetes and aging depending on composition of HDL particles [57].
In the ENVIRONAGE cohort we explored if being SGA was a significant predictor of the omic markers
identified in our study. Methylation levels of cg05119988 and cg17901584 located on SC4MOL and
DHCR24 genes were higher in SGA compared to LGA, and methylation of cg17901584 was lower in LGA
compared to AGA. Cord blood levels of the two CpGs have been previously associated with birthweight
[9], but never before to SGA. In our study the methylation of these CpGs was further positively associated
with total level of cord blood cholesterol and positively correlated with plasmalogen PC(36:4)/PC(O-36:5)
and PC(34:2). Interestingly, previous research has associated methylation of cg17901584 with waist
circumference, PC(36:5) C and with HDL cholesterol in adults [[58], [59], [60]].
Our analysis had a number of weaknesses. Cord blood includes a mixture of cell-types that may
demonstrate similar phenotypes but with distinct methylation and gene expression patterns [61,62]. The
protein-set was limited to inflammatory proteins (n = 16) and the metabolome analysis was limited to a
single analytical platform with many metabolites lacking annotation, which is common in metabolomics
analyses [63]. Also, the curation of human pathway databases is incomplete and possibly biased towards
specific diseases. Although we were not able to analyze genomic data in the same samples, we did not find
in silico evidence of genetic variants influencing the DNA methylation sites. While we hypothesized that
birthweight influences biomarkers at different omic levels, the cross-sectional study design does not allow
assessment of causality and therefore we cannot exclude the possibility that the biomarkers themselves are
responsible for birthweight modifications. In this regard, a recent multi-omic study in adults found through
mendelian randomization that methylation of one of the two CpGs common to our methylation- and
metabolite-driven integrations of omics (cg17901584) seems to be a consequence rather than a cause of
obesity [64]. In sensitivity analyses we found differences by sex but we were not able to detect a clear
pattern.
The major strengths of our study are the combination of cord blood samples from four different European
birth-cohorts and an integrative analysis of different omic levels accompanied by computational and
technical challenges. We acknowledge that our results may be affected by differences in birthweight across
individual cohorts (Table 1), however the top signals in the two approaches were unaffected by factors
differing between cohorts, indicating that study heterogeneity is not the main driver of our findings.
Different methods have been described to integrate data obtained from different omic levels [31,65]. Our
approach combines multi-omics correlation with pathway and network correlation analysis and aimed at
identifying the intermediate biological mechanisms that link birthweight-related omic signatures from the
same individuals.
The translational potential of our results lays in the development of an extensive catalog of birthweight
associated signals. In observational studies, birthweight has repeatedly been associated with a variety of
later-life diseases [[4], [5], [6], [7]]. In the context of the DOHaD, the signals we found may reflect
biomolecular changes exhibiting possible health effects later in life. For example, among the key signatures
we identified, lower levels of cord blood PCs had been recently associated with higher risk of pulmonary
hypertension in infants [66] and cord blood CCL22 has been associated with IgE sensitization in two
year-old children [67]. Further, the finding of low levels of total and HDL cholesterol in SGA compared to
AGA and LGA respectively, and that methylation of CpGs identified in our multi-omic study differed in
SGA compared to LGA suggest a possible route for tailored intervention in SGA newborns that have
higher risk of morbidity and mortality both in the perinatal period and in later life [68]. Although multiple
molecular layers are linked via complex mechanisms, multi-omics integration, such as in our study, can
further clarify relations between the different omics and enable us to study early life dynamics of
molecular signals. Before we can translate this knowledge into general applications, the causality of the
identified associations should be studied by longitudinal and in vivo experimental studies.
In conclusion, we further substantiated previously identified biomarkers in cord blood linked to birthweight
and identified new omic features. Our data suggested that cholesterol and related metabolic pathways are
related to birthweight. Our results provide evidence that integration of different omic layers is a useful tool
to generate hypotheses on mechanistic pathways. Further studies are required to discover the role of these
biomarkers in later life diseases.
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Figures and Tables
Fig. 1
Research hypothesis. The diagram exemplifies the central role of omics in the hypothetical path that drives the present study
and according to which birthweight induces molecular modifications that in turn influence the later life health and disease
(red arrows); and the alternative pathways where in utero exposures cause the changes in the omic layers leading to variation
of birthweight (grey arrows).
Fig. 2
Open in a separate window
Study design. The figure shows the main analysis exploring the structure across omic profiles in the four EXPOsOMICS
cohorts and the subsequent pathways analysis, network correlation analysis, in silico identification of methylation
quantitative trait loci, and the follow-up analysis exploring key findings in the ENVIRONAGE cohort.
Table 1
Characteristics of the EXPOsOMICS population (by cohort) and the full ENVIRONAGE
population.












Birthweight, g 3389·28 ± 478·29 3305·98 ± 399·33 3217·06 ± 431·42 3258·90 ± 429·69 8·85e−03 3413·01
Birthweight, –
 SGA (<10 Pi) 14 (7·2) – – – 76 (6·9)
 AGA
(≥10 Pi& ≤ 90thPi)
155 (79·5) – – – 880 (80
 LGA (>90  Pi) 25 (12·8) – – – 141 (12
Gestational age,
weeks
39·14 ± 1·53 39·71 ± 1·41 39·57 ± 1·58 38·43 ± 1·32 2·66e−09 39·22 ±
Girls 95 (49·0) 50 (51·5) 43 (44·3) 47 (47·0) 0·77 530 (48
Maternal age, years 29·41 ± 4·43 31·48 ± 4·14 33·28 ± 4·46 30·03 ± 4·99 8·25e−11 29·41 ±
Maternal BMI,
Kg/m
23·94 ± 4·06 23·45 ± 3·83 22·63 ± 3·87 25·09 ± 5·37 7·87e−04 24·52 ±
Maternal weight,
Kg
66·09 ± 11·88 62·52 ± 11·20 60·95 ± 11·16 66·76 ± 15·64 9·28e−04 67·82 ±
Maternal height, cm 166·14 ± 6·81 163·15 ± 6·60 164·05 ± 5·70 162·93 ± 5·65 3·22e−05 166·189
Maternal smoking 25 (12·9) 23 (24·0) 20 (20·6) 20 (20·2) 0·09 134 (12
Maternal education 1·57e−03
 Primary school 27 (14·6) 17 (17·5) 8 (8·2) 8 (8·1) 139 (12
 Secondary school 63 (34·1) 46 (47·4) 40 (41·2) 57 (57·6) 393 (35
 University of
higher
95 (51·4) 34 (35·1) 49 (50·5) 34 (34·3) 565 (51
Multiparity 87 (44·8) 43 (44·8) 51 (52·6) 70 (71·4) 1·16e−04 511 (46·
Paternal age, years 31·75 ± 5·89 33·46 ± 4·35 36·47 ± 5·57 34·24 ± 5·04 1·94e−10 31·95 ±
Paternal BMI,
Kg/m
25·78 ± 3·46 27·20 ± 3·90 24·97 ± 3·03 25·99 ± 4·49 1·06e−03 25·96 ±
Paternal weight, Kg 83·43 ± 15·94 81·11 ± 13·36 78·43 ± 10·65 84·97 ± 14·47 5·97e−03 83·65 ±
Paternal height, cm 179·07 ± 7·54 177·08 ± 6·80 177·20 ± 6·30 176·38 ± 7·21 0·01 179·49 ±
Open in a separate window
Counts (percentages) and means ± standard deviations are reported for categorical and continuous variables,
respectively.
AGA = adequate for gestational age; LGA = large for gestational age; Pi = percentile calculated for Flanders from the







P-value for associations between the four EXPOsOMICs birth-cohort. P-values <0·05 are marked in bold.
Between the pooled EXPOsOMICs population and the full ENVIRONAGE population are detected with analysis of





Significant correlations in the metabolite-driven integration of omics. A The circular plot displays the results of metabolite-
driven integration of omics. Tracks from outside to inside are: ideogram, histogram plot and significant links between omic
signals. The ideogram shows the omic features significantly correlated grouped in metabolites (green), CpGs (blue),
transcripts (orange) and inflammatory proteins (yellow). On the ideogram, features are identified by numbers as reported in
the Supplementary Table 27. Alternating bands distinguish classes of metabolites and proteins, genomic regions of genes
associated to CpGs and chromosomes on which are located the genes associated to transcripts. The histogram shows for
each omic feature (on the x-axis) the scaled percentage of significant correlations per each omic set as identified by colors
(on the y-axis in increasing order from outside to inside). In the center of the circular plot each significant correlation
coefficient is visualized through a link connecting the two correlated omics. Links are colored according to the sign of the
correlation coefficient, where red and blue links mean respectively positive and negative correlations. Thickness of the links
grows according to increasing absolute value of correlation coefficients. B The venn diagram shows the count of
metabolites significant in the metabolite-inflammatory protein, metabolite-transcriptome and metabolite-methylome
analyses represented in yellow, orange and blue circles respectively, and their intersections. C The dot plot shows significant
pathways grouped by function, from overrepresentation analysis (ORA) of the transcripts and the CpGs identified in the
metabolite-driven integration of omics. Dots size varies according the gene ratio and colors according the p-values. D The
network chart shows results from correlation network analysis. The nodes represent the omic features. Nodes are colored
according the omic layer they belong to (metabolites in green, CpGs in blue, transcripts in orange and inflammatory proteins
in yellow) and are identified by numbers as reported in the Supplementary Table 27. Only nodes with degree>2 and edges
with Bonferroni corrected p-values <0·05 are displayed. Hedges are colored according to the sign of the correlation
coefficient, where red and blue links mean respectively positive and negative correlations. Communities (groups 1–4),
detected using the Louvain algorithm, are marked by circles.
TSS = transcription start site; UTR = untranslated region; GFs = growth factors.
Table 2







Samples 489 164 460
Correlation pairs 1088 1,983,152 28,394,896
P-value threshold 4·60e−05 2·52e−08 1·76e−09
Significant correlations
 Correlation pairs 133 (12·2) 129 (0·006) 85 (0·0002)






 r absolute values
range
0·18–0·44 0·42–0·54 0·28–0·39
 Negative r 43 (32·33) 0 (0) 70 (82·35)
Counts (percentages) are reported. r = correlation coefficient.
Fig. 4
Significant correlations in the methylation-driven integration of omics. A The circular plot depicts the results of the
methylation-driven integration of omics. Tracks from outside to inside are: ideogram, histogram plot and significant links
between omic signals. The ideogram shows the omic features significantly correlated grouped in CpGs (blue), metabolic
features (green), transcripts (orange) and inflammatory proteins (yellow). On the ideogram, features are identified with
numbers as reported in the Supplementary Table 28. Alternating bands distinguish classes of metabolites and proteins,
genomic regions of genes associated to CpGs and chromosomes on which are located the genes associated to transcripts.
The histogram shows for each omic feature (on the x-axis) the scaled percentage of significant correlations per each omic set
as identified by colors (on the y-axis in increasing order from outside to inside). In the center of the circular plot each
significant correlation coefficient is visualized through a link connecting the two correlated omics. Links are colored
according to the sign of the correlation coefficient, where red and blue links mean respectively positive and negative
correlations. Thickness of the links grows according to increasing absolute value of correlation coefficients. B The dot plot
shows significant pathways, grouped by function, from overrepresentation analysis (ORA) of the transcripts identified in the
methylation-driven integration of omics. Dots size varies according the gene ratio and colors according the p-values. C
Metabolic network visualization of significantly enriched pathways based on the manually curated KEGG global metabolic
network [34]. The metabolites of significantly enriched pathways are represented as nodes on the network. Empty nodes
represent compounds identified from the feature list by mummichog but not significant, while solid nodes represent
significantly enriched features. Note not all metabolites from the KEGG global network are displayed. D The venn diagram
shows the count of significant CpGs in the CpG-inflammatory protein, CpG -transcriptome and CpG-metabolic feature
analyses represented in yellow, orange and green circles respectively, and their intersections. E The network chart shows
results from correlation network analysis. The nodes represent the omic features. Nodes are colored according the omic
layer they belong to (metabolites in green, CpGs in blue, transcripts in orange and inflammatory proteins in yellow) and are
identified by numbers as reported in the Supplementary Table 28. Only nodes with degree>2 and edges with Bonferroni
corrected p-values <0·05 are displayed. Hedges are colored according to the sign of the correlation coefficient, where red
and blue links mean respectively positive and negative correlations. Communities (groups 1–6), detected using the Louvain
algorithm, are marked by circles.
TSS = transcription start site; UTR = untranslated region.
Table 3







Samples 450 162 460
Correlation pairs 14,448 26,335,092 4,254,936
P-value threshold 3·46e−06 1·89e−09 1·17−08
Significant correlations
 Correlation pairs 4 (0·03) 439 (0·002) 39 (0·0009)





24 metabolic features (0·51)
 r absolute values
range
0·22–0·24 0·45–0·57 0·26–0·39
 Negative r 3 (75) 403 (91·80) 8 (20·51)
Counts (percentages) are reported. r = correlation coefficient.
Fig. 5
Significant correlations common to the metabolite- and the methylation-driven integrations of omics. The figure represents
the 48 significant correlations identified by the seven omics commonly significant in the metabolite- and the methylation-
driven integrations of omics. A In the circular plot tracks from outside to inside are: ideogram, histogram plot and
significant links between omic signals. The ideogram shows the omic features significantly correlated grouped in
metabolites (green), CpGs (blue) and inflammatory proteins (yellow). On the ideogram features are identified by numbers as
reported in the Supplementary Table 29. Alternating bands distinguish classes of metabolites and proteins, and genomic
regions of genes associated to CpGs. The seven common omic features are highlighted in red. The histogram plot shows for
each omics feature (on the x-axis) the scaled percentage of significant correlations (on the y-axis in increasing order from
outside to inside). In the center of the circular plot each significant correlation coefficient is visualized through a link
connecting the two correlated omics. Links are colored according to the sign of the correlation coefficient, where red and
blue links mean respectively positive and negative correlations. Thickness of the links grows according to increasing
absolute value of correlation coefficients. B The venn diagram shows among the seven common omic features how many
are significantly correlated with inflammatory proteins, transcripts and metabolites represented in yellow, orange and green
circles respectively, and their intersections. C The network chart shows results from correlation network analysis. The nodes
represent the omic features. Nodes are colored according the omic layer they belong to (metabolites in green, and CpGs in
blue) and are identified by omic names. Only nodes with degree>2 and edges with Bonferroni corrected p-values <0·05 are
displayed. Hedges are colored according to the sign of the correlation coefficient, where red and blue links mean respectively
positive and negative correlations. Communities (groups 1–2), detected using the Louvain algorithm, are marked by circles.
D The dot plot shows significant pathways grouped by function, from overrepresentation analysis (ORA) of the transcripts
identified in the metabolite- and methylation-driven integration of omics. Dots size varies according the gene ratio and
colors according the p-values.
TSS = transcription start site; UTR = untranslated region * intersection only between proteins and metabolites.
Table 4
Results from the cholesterol analyses.








Metabolites n = 182 n = 182 n = 182
 PC(34:2) 17·08 7·82e−04 2·66 0·16 −1·07 0·48
 Plasmalogen
PC(36:4)/PC(O-36:5)
26·85 3·05e−07 5·28 0·01 −1·17 0·48
 U61 17·70 3·32e−04 1·14 0·54 1·72 0·24
CpGs n = 178–179 n = 178–179 n = 178–179
cg05119988 6·02 7·45e−03 0·55 0·51 0·17 0·80
cg17901584 6·87 1·56e−03 0·86 0·29 0·58 0·38
Proteins , n = 176 n = 176 n = 176
 CCL22 −5·39 0·25 −2·88 0·09 0·90 0·51
 Periostin 8·19 0·09 −2·70 0·13 0·89 0·52
P-values <0.05 are marked in bold. CCL22 = macrophage-derived chemokine; change = change in cholesterol levels (in
mg/dl) for one interquartile range increment of metabolites, CpGs and proteins; HDL = high-density lipoprotein;
LDL = low-density lipoprotein; n = numbers of observation; PC = phosphatidylcholine; U61 = unassigned metabolite 61.
All the analyses are adjusted for gestational age, newborn sex, maternal age, maternal height, maternal BMI, smoking
during pregnancy, parity, maternal education, and total cholesterol levels (for HDL and LDL analyses).
Analyses of proteins were additionally adjusted on plate and analyses of CpGs were additionally adjusted for chip,







Cholesterol levels in ENVIRONAGE cohort. A Total, B HDL and C LDL cholesterol levels in cord blood (on the y-axis) in
SGA, AGA and LGA newborns (on the x-axis) of the ENVIRONAGE cohort (n = 1097) are graphically represented by
boxplots.
AGA = adequate for gestational age; LGA = large for gestational age; SGA = small for gestational age.
*p-value between SGA and AGA and ** between SGA and LGA from linear multivariate analysis adjusted for gestational
age, newborn sex, maternal age, maternal height, maternal BMI, maternal smoking during pregnancy, parity, maternal
education, and cord blood total cholesterol levels (for HDL and LDL analyses) < 0·05.
